Eric C Wilmhurst

Title: Eric C Wilmhurst: Innovator in Therapeutic Agents

Introduction

Eric C Wilmhurst is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of depression. His innovative work has led to the development of a patent that showcases his expertise and dedication to improving healthcare.

Latest Patents

Eric C Wilmhurst holds a patent for therapeutic agents, specifically compounds of formula I. This patent describes various compounds where R1 is a C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-7 cycloalkyl, cycloalkylalkyl, or optionally substituted phenyl. The patent also details that R2 can be H or C1-3 alkyl, while R3 and/or R4 can be H, formyl, C1-3 alkyl, C3-6 alkenyl, C3-6 alkynyl, or C3-7 cycloalkyl. Additionally, R5 and/or R6 can be H, halo, CF3, C1-3 alkyl, C1-3 alkoxy, C1-3 alkylthio, or can form a second benzene ring with the carbon atoms to which they are attached. These compounds show therapeutic activity in treating depression, and the patent also discloses pharmaceutical compositions and processes for preparing these compounds.

Career Highlights

Eric C Wilmhurst is associated with The Boots Company Plc, a prominent player in the pharmaceutical industry. His work at this company has allowed him to focus on developing innovative solutions for mental health treatment. His dedication to research and development has positioned him as a key figure in the field of therapeutic agents.

Collaborations

Eric has collaborated with notable colleagues such as James Edward Jeffery and Antonin Kozlik. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Eric C Wilmhurst is a distinguished inventor whose work in therapeutic agents has the potential to make a significant impact on the treatment of depression. His innovative patent and collaborations highlight his commitment to advancing healthcare solutions.